Trade Summary

2 days ago, Rallis Chris A, serving as Dir at Fennec Pharmaceuticals Inc. (FENC), sold 8,346 shares at $7.04 per share, for a total transaction value of $58,756.00. Following this transaction, Rallis Chris A now holds 63,077 shares of FENC.

This sale represents a 12.00% decrease in Rallis Chris A's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, May 11, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, May 12, 2026, 1 day after the trade was made.

Fennec Pharmaceuticals Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.